Multi-System Atrophy Flashcards

1
Q

what are the features of autonomic dysfunction

A

postural hypotension (dizzy, lightheaded, faint)

urinary frequency,

incontinence,

dysarytmias (palpitations),

sexual dysfunction (impotence)

bowel symptoms (constipation, diarrhoea)

problems with temperature regulation,

sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the prevalence of MSA?

A

1.9 to 4.9 per 100,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the mean age of onset of MSA

A

58 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mean survival of MSA is

A

7 to 9 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the percentage distribution of MSA

A

MSA-P 58%

MSA-C 42% .

In japan 84% have MSA-C ,

equal female to male ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the principles of the MSA diagnostic criteria?

A

combination of clinical features of the disease and criteria, a feature (A) is characteristic of the disease, a criterion (B) is a defining feature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the diagnostic criteria for MSA- autonomic dysfunction

A

A)

(1) orthostatic hypotension
(2) urinary incontinence or incomplete bladder emptying

B: criterion: orthostatic fall of BP by 30 mmhg or 15mmhg diastolic

or urinary incontinence accompanied by erectile dysfunction

or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the diagnostic criteria for MSA-parkinsonism

A

A)

1) bradykineasia,
2) rigidity,
3) postural instability,
4) tremor

b) criterion: bradykinesia plus at least one of items 2 to 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the diagnostic criteria for crebellar dysfunction MSA

A

a)

1) gait ataxia,
2) ataxic dysarthria
3) limb ataxia
4) gaze evoked nystagmus

B) criterion: gait ataxia plus at least one of items 2-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the diagnostic categories for MSA

A

possible MSA:

one criterion plus 2 features from separate other domains

PROBABLE MSA: criterion for autonomic failure plus poorly levadopa responsive parkinsonism or cerebellar dysfunction,

DEFINITE MSA: pathologically confirmed high density of glial cytoplasmic inclusions in association with degenerative changes in striatonigral and olivopontocerebellar pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the prevalence of MSA-C amongst ataxias?

A

familial ataxias: 31% sporadic ataxias 69%

MSA-C accounts for 9% all ataxias and 13% sporadic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the incidence of MSA-P amongst patients with idiopathic parkinsons disease

A

1.9 per 100,000 compared to 105-179 per 100,000 PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the clinical features of MSA

A

partial or no response to L-dopa,

early instability and falls,

no dyskinesias with levadopa,

marked dysarthria early on particularly in MSA-C,

neck dystonia (anterocollis),

new snoring,

vivid dreams (REM sleep disorder)

sleep apnoea,

irregular jerky tremor or myoclonus in hands,

erectile dysfunction,

pathological laughter or crying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are some non-supportive features of MSA

A

pill rolling,

peripheral neuropathy,

onset younger than 30 or over 75,

family history,

dementia/cognitive decline,

vertical supranuclear gaze palsy (PSP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what investigations can be useful for MSA?

A

autonomic function tests (although sometimes not necessary),

clinical history most useful,

other tests:
sphincter EMG,

24hour BP and HR,

SPECT and PET looking at postsynaptic D2 receptors (lost in MSA)

MRI useful in diagnosis (hot cross bun) MR spectroscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the pathology of MSA

A

misfolding, aggregation and fibrilation of alphasynuclein,

forms glial cytoplasmic inclusions, d

istribution of GCI dictates presentation (cerebellar v parkinsonian)

17
Q

what is the difference in pathology between sporadic parkinsons and MSA

A

parkinsons: lewy body inclusions,

MSA: glial cytoplasmic inclusions

18
Q

how can MSA be managed?

A

trial of L-Dopa,

orthostatic hypotension:

elastic stockings,
high salt intake, ephedrine,
midrodrine.

Bladder dysfunction: oxybutin

Respiratory problems: supportive ventilation (sleep apnoea),

citalopram for innapropriate laugter

19
Q

what experimental approaches have been trialed in MSA

A

riluzole: no benefit,
minocycline: no benefit,
resagline: currently on trial.

Currently no effective treatment